CSI Market
Sign In | Register

West Pharmaceutical Services Inc (WST) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access WST Annual Cash Flow →
The quarterly cash flow data below helps track how West Pharmaceutical Services Inc's liquidity profile has evolved over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income292.80
Depreciation & amortization91.40
Amortization of Other Assets1.10
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges11.10
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation17.50
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions9.50
Gains (Losses) on Extinguishment of Debt-3.00
Restructuring Reserve Settled Without Cash0.90
Payment For Contingent Consideration Liability Operating Activities-
Pension And Other Postretirement Benefit Expense Net-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital188.90
Other Noncash Income (Expense)5.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-400.40
Discontinued operations0.00
Net Cash flow from Operating Activities213.90
Investing Activities
Capital Expenditures-85.90
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross0.00
Payments to Acquire Interest in Subsidiaries and Affiliates0.00
Cash Divested from Deconsolidation0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-85.90
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings50.00
Long-term debt - repayments-50.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-438.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-2.50
Other net-1.50
Tax Benefit From Stock Options Exercised-
Tax Benefit From Stock Options Exercised-
Finance Lease Principal Payments-0.30
Payments For Excise Tax-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid-31.50
Net Cash Flow from Financing Activities-473.50
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow128.00
Total Cash Flow-355.50
4 historic quarters locked

Sign in to unlock the full West Pharmaceutical Services Inc cash flow history.

Sign In Create Free Account

About West Pharmaceutical Services Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: July 23, 2026
  • Source: wst-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000105770-26-000099

Figures are derived from filed reports and may be restated. Historical data is subject to revision.